4.6 Article

Diosmetin inhibits cell proliferation and promotes apoptosis through STAT3/c-Myc signaling pathway in human osteosarcoma cells

期刊

BIOLOGICAL RESEARCH
卷 54, 期 1, 页码 -

出版社

SOC BIOLGIA CHILE
DOI: 10.1186/s40659-021-00363-1

关键词

Diosmetin; Osteosarcoma; Signal transducer and activator of transcription 3 (STAT3); Cell proliferation; Apoptosis

类别

资金

  1. National Natural Science Foundation of China [81973329, 82073858, 81773741]
  2. Shanghai Jiao Tong University Scientific and Technological Innovation Funds [19X160010005]
  3. Medical-Engineering Cross Fund of Shanghai Jiao Tong University [YG2019QNA55]

向作者/读者索取更多资源

The study showed that Diosmetin has significant inhibitory effects on cell proliferation and can induce cell cycle arrest and apoptosis in osteosarcoma cells. It achieves anti-osteosarcoma effects by regulating the expression of apoptotic proteins and inhibiting the activation of the STAT3/c-Myc signaling pathway.
Background Diosmetin is a bioflavonoid compound naturally abundant in citrus fruits. It is found to perform a variety of activities, while its antitumor property in osteosarcoma, a malignant tumor with unmet clinical treatment, remained unknown. Methods Colony formation assay, cell cycle analysis and apoptosis analysis were conducted respectively to observe the effect of diosmetin on cell proliferation and apoptosis in human osteosarcoma cells. Western blot and immunoprecipitation were used to detect the expression of apoptotic molecules and activation of STAT3/c-Myc pathway in Saos-2 and U2SO cells. Results Diosmetin significantly inhibited cell proliferation, induced cell cycle arrest at G2/M phase and promoted cell apoptosis in both Saos-2 and U2SO cells. Moreover, Diosmetin downregulated the expression of anti-apoptotic protein Bcl-xL while upregulated the levels of pro-apoptotic proteins including cleaved Caspase-3, cleaved-PARP and Bax. Furthermore, diosmetin dose-dependently inhibited STAT3 phosphorylation, reduced the expression of its downstream protein c-Myc and impeded the interaction between STAT3 molecules. Conclusions These results suggest that diosmetin exerts anti-osteosarcoma effects by suppressing cell proliferation and inducing apoptosis via inhibiting the activation of STAT3/c-Myc signaling pathway, which provide the possibility for diosmetin to be a chemotherapeutic candidate for osteosarcoma.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据